Ensysce Biosciences shares are trading lower. The company announced the publication of first clinical manuscript describing its Multi-Pill Abuse Resistance overdose protection technology.

Ensysce Biosciences, Inc. -6.22%

Ensysce Biosciences, Inc.

ENSC

0.41

-6.22%

Ensysce Biosciences shares are trading lower. The company announced the publication of first clinical manuscript describing its Multi-Pill Abuse Resistance overdose protection technology.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via